DANIEL MORIN

Dr. DANIEL MORIN


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 July 2017 in EP Europace
Verified
Journal Article
Open access
PDF file
BGBulent Gorenek
Bulent Gorenek
JBJeroen Bax
Jeroen Bax
GBGiuseppe Boriani
Giuseppe Boriani
SCShih-Ann Chen
Shih-Ann Chen
NDNikolaos Dagres
Nikolaos Dagres
CLCarina Blomstrom Lundqvist
Carina Blomstrom Lundqvist
Atrial high rate event (AHRE): atrial high-rate episodes are defined as atrial tachyarrhythmia episodes with rate >190 beats/min detected by cardiac implantable electronic devices.

1 December 2016 in Mayo Clinic Proceedings
Verified
Journal Article
Closed access
DMDANIEL MORIN
DANIEL MORIN
MBMichael L. Bernard
Michael L. Bernard
CMChristopher Madias
Christopher Madias
PRPaul A. Rogers
Paul A. Rogers
STSudarone Thihalolipavan
Sudarone Thihalolipavan
NEN.A. Mark Estes
N.A. Mark Estes

1 April 2013 in Mayo Clinic Proceedings
Verified
Journal Article
Closed access
AMArthur R. Menezes
Arthur R. Menezes
CLCarl J. Lavie
Carl J. Lavie
JDJames J. DiNicolantonio
James J. DiNicolantonio
JOJames O'KEefe
James O'KEefe
DMDANIEL MORIN
DANIEL MORIN
RMRichard V. Milani
Richard V. Milani

3 March 2020 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
PDF file
JOJeffrey E. Olgin
Jeffrey E. Olgin
BLByron K. Lee
Byron K. Lee
EVEric Vittinghoff
Eric Vittinghoff
DMDANIEL MORIN
DANIEL MORIN
SZSteven Zweibel
Steven Zweibel
MPMark J. Pletcher
Mark J. Pletcher

1 March 2016 in JACC
Verified
Journal Article
Closed access
GBGabriel C. Brooks
Gabriel C. Brooks
BLByron K. Lee
Byron K. Lee
RRRajni Rao
Rajni Rao
FLFeng Lin
Feng Lin
DMDANIEL MORIN
DANIEL MORIN
JOJeffrey E. Olgin
Jeffrey E. Olgin

25 January 2012 in EP Europace
Verified
Journal Article
Open access
PDF file
DMDANIEL MORIN
DANIEL MORIN
MSMarc N. Saad
Marc N. Saad
OSOmar F. Shams
Omar F. Shams
JOJ. Sam Owen
J. Sam Owen
JXJoel Q. Xue
Joel Q. Xue
RMRichard V. Milani
Richard V. Milani
The interval between the T-wave's peak and end (Tpe), an electrocardiographic (ECG) index of ventricular repolarization, has been proposed as an indicator of arrhythmic risk. We aimed to clarify the clinical usefulness of Tpe for risk stratification. We evaluated 327 patients with left ventricular ejection fraction (LVEF) ≤35% (75% male, LVEF 23 ± 7%). All patients had an implanted implantable cardioverter-defibrillator (ICD). Clinical data and ECGs were analysed at baseline. Prospective follow-up for the endpoints of appropriate ICD therapy and mortality was conducted via periodic device interrogation, chart review, and the Social Security Death Index. During device clinic follow-up of 17 ± 12 months, 59 (18%) patients had appropriate ICD therapy, and during mortality follow-up of 30 ± 13 months, 67 (21%) patients died. A longer Tpec predicted appropriate ICD therapy, death, and the combination of appropriate ICD therapy or death (P< 0.01 for each endpoint). On multivariable analysis correcting for other univariable predictors, Tpec remained predictive of ICD therapy [hazard ratio (HR) per 10 ms increase: 1.16, P= 0.02], all-cause mortality (HR per 10 ms: 1.14, P= 0.03), and the composite endpoint of ICD therapy or death (HR per 10 ms: 1.16, P< 0.01). In patients with left ventricular systolic dysfunction and an implanted ICD, Tpec independently predicts both ventricular tachyarrhythmia and overall mortality.